EUVIMEDEUVIMED entdecken
Open Access

Immune checkpoint inhibitor–related eruptive keratoacanthoma

Kazuki Watanabe, Mitsuhito Ota

Canadian Medical Association Journal · 01.06.2026 · 198 (21) · E836-E837

DOI: 10.1503/cmaj.252150 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Canadian Medical Association Journal, online erschienen am 31.05.2026. Verfasst von Kazuki Watanabe und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Chitose City Hospital, Chitose, Japan. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Dermatology, Chitose City Hospital, Chitose, Japan.
  • Department of Dermatology, Chitose City Hospital, Chitose, Japan. ota@med.hokudai.ac.jp.

Zitieren

APA

Watanabe, K., & Ota, M. (2026). Immune checkpoint inhibitor–related eruptive keratoacanthoma. Canadian Medical Association Journal, 198(21), E836-E837. https://doi.org/10.1503/cmaj.252150

Vancouver

Watanabe K, Ota M. Immune checkpoint inhibitor–related eruptive keratoacanthoma. Canadian Medical Association Journal. 2026;198(21):E836-E837. doi:10.1503/cmaj.252150

BibTeX
@article{Watanabe2026,
  author = {Watanabe, Kazuki and Ota, Mitsuhito},
  title = {Immune checkpoint inhibitor–related eruptive keratoacanthoma},
  journal = {Canadian Medical Association Journal},
  year = {2026},
  volume = {198},
  number = {21},
  pages = {E836--E837},
  doi = {10.1503/cmaj.252150}
}
Kostenlos starten →